{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:29:12Z","timestamp":1762522152736},"reference-count":60,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2018,4,3]]},"DOI":"10.1080\/17474086.2018.1449637","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T12:34:08Z","timestamp":1520598848000},"page":"293-300","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Current and emerging treatment options for a patient with a second relapse of Hodgkin\u2019s lymphoma"],"prefix":"10.1080","volume":"11","author":[{"given":"Avyakta","family":"Kallam","sequence":"first","affiliation":[{"name":"Division of Oncology\/Hematology, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James O.","family":"Armitage","sequence":"additional","affiliation":[{"name":"Division of Oncology\/Hematology, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.5.1395"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92411-L"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08938-9"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.3.616"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07727.x"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.177"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60165-9"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.13.2615"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04226.x"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm090"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20587"},{"issue":"4","key":"CIT0013","first-page":"323","volume":"83","author":"Brusamolino E","year":"1998","journal-title":"Haematologica"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.3308"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2015.02.023"},{"key":"CIT0017","volume":"293","author":"LaCasce A","year":"2014","journal-title":"ASH Annu Meet Abstr"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.022"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2016.09.008"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66659-7"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.13441"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.08.014"},{"issue":"30","key":"CIT0023","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1200\/JCO.2017.72.6869","volume":"35","author":"Mart\u00ednez C","year":"2017","journal-title":"J Clin Oncol"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.348"},{"issue":"18","key":"CIT0025","volume":"24","author":"Chau I","year":"2013","journal-title":"Ann Oncol"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2015.1044432"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.2217\/imt.11.15"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002965"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1425"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.0410"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08-595801"},{"key":"CIT0032","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.2736.2736","volume-title":"Five-year survival data demonstrating durable responses from a pivotal phase 2 study of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma","author":"Chen R","year":"2015"},{"key":"CIT0033","volume-title":"FDG-PET adapted sequential therapy with brentuximab vedotin and augmented ICE followed by autologous stem cell transplant for relapsed and refractory Hodgkin lymphoma","author":"Schoder H","year":"2013"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2013.88"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-418673"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.06.037"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-397893"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-7-24"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.876496"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.2217\/BMM.15.30"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411087"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30167-X"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-738385"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx341"},{"key":"CIT0045","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.3979.3979","volume-title":"Nivolumab is effective and reasonably safe in relapsed or refractory Hodgkin\u2019s lymphoma after allogeneic hematopoietic cell transplantation: a study from the lysa and SFGM-TC","author":"Herbaux C","year":"2015"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.3467"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1177\/2040620717695723"},{"key":"CIT0048","volume-title":"Pembrolizumab in relapsed\/refractory classical Hodgkin lymphoma: primary end point analysis of the phase 2 Keynote-087 Study","author":"Moskowitz CH","year":"2016"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.2217\/fon.09.36"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.1350"},{"key":"CIT0051","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.1644.1644","volume-title":"A phase I trial of the Histone Deacetylase (HDAC) inhibitor, panobinostat, in combination with lenalidomide in patients with relapsed\/refractory Hodgkin\u2019s lymphoma (HL)","author":"Christian B","year":"2012"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1359741"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70265-0"},{"issue":"5","key":"CIT0054","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ajh.21664","volume":"85","author":"Johnston PB","year":"2010","journal-title":"Am J Hematol"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-362475"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2013-0407"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/968212"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.5223"},{"key":"CIT0059","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2015.33.15_suppl.8520","volume-title":"Interim analysis of a phase I study of INCB040093, a PI3K\u03b4 inhibitor, alone or in combination with INCB039110, a selective JAK1 inhibitor, in patients (pts) with relapsed or refractory (r\/r) B-cell malignancies","author":"Phillips TJ","year":"2015"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1505857"},{"issue":"1","key":"CIT0061","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/asheducation-2017.1.317","volume":"2017","author":"Bartlett NL","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1172\/JCI94306"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2018.1449637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T22:21:29Z","timestamp":1719872489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2018.1449637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,3,7]]},"published-print":{"date-parts":[[2018,4,3]]}},"alternative-id":["10.1080\/17474086.2018.1449637"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2018.1449637","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}